Cost Minimization Analysis of Using Pazopanib in First-Line Treatment in Patients with Metastatic Renal Cell Carcinoma
Nov 1, 2016, 00:00
10.1016/j.jval.2016.09.2244
https://www.valueinhealthjournal.com/article/S1098-3015(16)33610-5/fulltext
Title :
Cost Minimization Analysis of Using Pazopanib in First-Line Treatment in Patients with Metastatic Renal Cell Carcinoma
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(16)33610-5&doi=10.1016/j.jval.2016.09.2244
First page :
A739
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
2132